These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Short hairpin RNA-mediated inhibition of measles virus replication in vitro. Shi JY; Liu B; Wang ML; Luo EJ Can J Microbiol; 2010 Jan; 56(1):77-80. PubMed ID: 20130697 [TBL] [Abstract][Full Text] [Related]
7. The phosphoprotein of attenuated measles AIK-C vaccine strain contributes to its temperature-sensitive phenotype. Komase K; Nakayama T; Iijima M; Miki K; Kawanishi R; Uejima H Vaccine; 2006 Feb; 24(6):826-34. PubMed ID: 16140429 [TBL] [Abstract][Full Text] [Related]
8. Glutathione is required for efficient production of infectious picornavirus virions. Smith AD; Dawson H Virology; 2006 Sep; 353(2):258-67. PubMed ID: 16860836 [TBL] [Abstract][Full Text] [Related]
9. Antagonism of buthionine sulfoximine cytotoxicity for human neuroblastoma cell lines by hypoxia is reversed by the bioreductive agent tirapazamine. Yang B; Keshelava N; Anderson CP; Reynolds CP Cancer Res; 2003 Apr; 63(7):1520-6. PubMed ID: 12670899 [TBL] [Abstract][Full Text] [Related]
10. [Antiviral activity of panavir in experimental Measles virus infection in cell cultures]. Markushin SG; Litvin AA Antibiot Khimioter; 2009; 54(1-2):14-6. PubMed ID: 19499711 [TBL] [Abstract][Full Text] [Related]
11. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme. Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267 [TBL] [Abstract][Full Text] [Related]
13. Coumarins and pyranocoumarins, potential novel pharmacophores for inhibition of measles virus replication. Barnard DL; Xu Ze; Stowell VD; Yuan H; Smee DF; Samy R; Sidwell RW; Nielsen MK; Sun L; Cao H; Li A; Quint C; Deignan J; Crabb J; Flavin MT Antivir Chem Chemother; 2002 Jan; 13(1):39-59. PubMed ID: 12180648 [TBL] [Abstract][Full Text] [Related]
14. Buthionine sulfoximine enhancement of arsenic trioxide-induced apoptosis in leukemia and lymphoma cells is mediated via activation of c-Jun NH2-terminal kinase and up-regulation of death receptors. Chen D; Chan R; Waxman S; Jing Y Cancer Res; 2006 Dec; 66(23):11416-23. PubMed ID: 17145888 [TBL] [Abstract][Full Text] [Related]
15. Effects of cyclophosphamide and buthionine sulfoximine on ovarian glutathione and apoptosis. Lopez SG; Luderer U Free Radic Biol Med; 2004 Jun; 36(11):1366-77. PubMed ID: 15135172 [TBL] [Abstract][Full Text] [Related]
16. Enhancement of arsenic trioxide-induced apoptosis in renal cell carcinoma cells by L-buthionine sulfoximine. Wu XX; Ogawa O; Kakehi Y Int J Oncol; 2004 Jun; 24(6):1489-97. PubMed ID: 15138592 [TBL] [Abstract][Full Text] [Related]
17. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Anderson BD; Nakamura T; Russell SJ; Peng KW Cancer Res; 2004 Jul; 64(14):4919-26. PubMed ID: 15256464 [TBL] [Abstract][Full Text] [Related]
19. [Study on characteristic of current measles wild-type strains after continuous passage from Vero cells]. Fu Y; Feng Y; Dong HJ Zhongguo Yi Miao He Mian Yi; 2010 Feb; 16(1):20-4. PubMed ID: 20450067 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide-induced apoptosis and its enhancement by buthionine sulfoximine in hepatocellular carcinoma cell lines. Kito M; Akao Y; Ohishi N; Yagi K; Nozawa Y Biochem Biophys Res Commun; 2002 Mar; 291(4):861-7. PubMed ID: 11866444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]